Related Experiment Video
Updated: Jan 21, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells
Roberto Silvestri1,2, Perla Pucci1, Erik Venalainen3
1School of Life Health and Chemical Sciences, The Open University, Milton Keynes, UK.
Background:
Androgen deprivation therapy (ADT) is the treatment of choice for metastatic prostate cancer (PCa). After an initial response to ADT, PCa cells can generate castration resistant (CRPC) or neuroendocrine (NEPC) malignancies, which are incurable. T-type calcium channels (TTCCs) are emerging as promising therapeutic targets for several cancers, but their role in PCa progression has never been investigated.
Methods:
To examine the role of TTCCs in PCa, we analyzed their expression level, copy number variants (CNV) and prognostic significance using clinical datasets (Oncomine and cBioPortal). We then evaluated TTCC expression in a panel of PCa cell lines and measured the effect of their inhibition on cell proliferation and survival using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and caspase assays.
Results:
TTCCs were upregulated in PCas harboring androgen receptor (AR) mutations; CNV rate was positively associated with PCa progression. Higher expression of one TTCC isoform (CACNA1G) predicted poorer postoperative prognosis in early stage PCa samples. Pharmacological or small interfering RNA (siRNA)-based inhibition of TTCCs caused a decrease in PC-3 cell survival and proliferation.
Conclusions:
Our results show that TTCCs are overexpressed in advanced forms of PCa and correlate with a poorer prognosis. TTCC inhibition reduces cell proliferation and survival, suggesting that there may be possible value in the therapeutic targeting of TTCCs in advanced PCa.
Insights
T-type calcium channels (TTCCs) are upregulated in advanced prostate cancer (PCa) and linked to poorer prognosis. Inhibiting TTCCs reduced PCa cell proliferation and survival, suggesting TTCCs as potential therapeutic targets for advanced PCa.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Androgen deprivation therapy (ADT) is standard for metastatic prostate cancer (PCa).
- Prostate cancer can evolve into incurable castration-resistant (CRPC) or neuroendocrine (NEPC) forms after ADT.
- The role of T-type calcium channels (TTCCs) in PCa progression remains unexplored.
Purpose of the Study:
- To investigate the expression, copy number variants (CNV), and prognostic significance of TTCCs in prostate cancer.
- To evaluate the effect of TTCC inhibition on prostate cancer cell proliferation and survival.
Main Methods:
- Analysis of TTCC expression and CNV in clinical PCa datasets (Oncomine, cBioPortal).
- Assessment of TTCC expression in PCa cell lines.
- Inhibition of TTCCs using pharmacological agents and small interfering RNA (siRNA).
- Measurement of cell proliferation (MTT assay) and survival (caspase assay).
Main Results:
- TTCCs were upregulated in PCa with androgen receptor (AR) mutations.
- Higher CNV rates correlated with PCa progression.
- Elevated expression of the TTCC isoform CACNA1G predicted worse outcomes in early-stage PCa.
- TTCC inhibition decreased PC-3 cell proliferation and survival.
Conclusions:
- TTCCs are overexpressed in advanced PCa and associated with poor prognosis.
- Inhibition of TTCCs demonstrates potential therapeutic value in advanced PCa by reducing cell proliferation and survival.
Related Concept Videos
Types of Receptors: Cell Surface Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Internal Receptors
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...

